Examining Vaccine Hesitancy Among Ghanaian Parents for the R21/Matrix-M Malaria Vaccine

被引:0
|
作者
Ghazy, Ramy Mohamed [1 ]
Kyei-Arthur, Frank [2 ]
Saleeb, Marina [3 ]
Kyei-Gyam, Sylvester [4 ]
Abutima, Theophilus [5 ]
Sakada, Ignatius Great [6 ]
Alshaikh, Ayoub [1 ]
Hussein, Mai [7 ]
Hussein, Mohamed Fakhry [8 ]
机构
[1] King Khalid Univ, Coll Med, Family & Community Med, Abha, Saudi Arabia
[2] Univ Environm & Sustainable Dev, Dept Environm & Publ Hlth, Somanya, Ghana
[3] MARS GLOBAL, Biostat Dept, London WC2H 9JQ, England
[4] Minist Gender Children & Social Protect, Dept Children, Accra, Ghana
[5] Univ Dev Studies, Dept Sociol & Anthropol, Nyankpala Campus, Nyankpala, Ghana
[6] Kwame Nkrumah Univ Sci & Technol, Dept Populat Family & Reprod Hlth, Kumasi, Ghana
[7] Egypt Minist Hlth & Populat, Clin Res Adm, Alexandria Hlth Affairs Directorate, Cairo, Egypt
[8] Alexandria Univ, High Inst Publ Hlth, Occupat Hlth & Ind Med Dept, Alexandria, Egypt
关键词
Malaria; vaccinations; vaccine refusal; endemic diseases; ATTITUDES;
D O I
10.1016/j.pedhc.2024.05.010
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Introduction: This study aimed to assess Ghanaian parental attitudes toward a new malaria vaccine, R21/Matrix-M, and its associated determinants. Method: A cross-sectional survey was conducted anonymously in July and August 2023 using snowball and convenience sampling techniques, using the Parental Attitude about Children Vaccination Scale. Results: A total of 818 individuals were included, 67.2% were females, their median age was 32 years, and 29.01% were hesitant to vaccinate their children. People living in forests, with younger children, having the youngest child aged 1-3 years, skipping antenatal care or scheduled vaccinations, and not being willing to give the R21/Matrix-M vaccine to children, were vaccine-hesitant. However, healthcare workers, those having a relative who died from malaria, and those who vaccinated their child against malaria were less hesitant. Discussion: A large sector of parents expressed willingness to vaccinate their children against malaria. Addressing parental hesitancy requires intervention programs targeting the identified factors and enhancing parental knowledge. J Pediatr Health Care. (2024) 38, 873-885
引用
收藏
页码:873 / 885
页数:13
相关论文
共 50 条
  • [21] Efficacy of a low-dose candidate malaria vaccine, R21 in adjuvant Matrix-M, with seasonal administration to children in Burkina Faso: a randomised controlled trial
    Datoo, Mehreen S.
    Natama, Magloire H.
    Some, Athanase
    Traore, Ousmane
    Rouamba, Toussaint
    Bellamy, Duncan
    Yameogo, Prisca
    Valia, Daniel
    Tegneri, Moubarak
    Ouedraogo, Florence
    Soma, Rachidatou
    Sawadogo, Seydou
    Sorgho, Faizatou
    Derra, Karim
    Rouamba, Eli
    Orindi, Benedict
    Lopez, Fernando Ramos
    Flaxman, Amy
    Cappuccini, Federica
    Kailath, Reshma
    Elias, Sean
    Mukhopadhyay, Ekta
    Noe, Andres
    Cairns, Matthew
    Lawrie, Alison
    Roberts, Rachel
    Valea, Innocent
    Sorgho, Hermann
    Williams, Nicola
    Glenn, Gregory
    Fries, Louis
    Reimer, Jenny
    Ewer, Katie J.
    Shaligram, Umesh
    Hill, Adrian V. S.
    Tinto, Halidou
    LANCET, 2021, 397 (10287): : 1809 - 1818
  • [22] HIGH LEVEL EFFICACY IN HUMANS OF A NEXT-GENERATION PLASMODIUM FALCIPARUM ANTI-SPOROZOITE VACCINE: R21 IN MATRIX-M™ ADJUVANT
    Venkatraman, Navin
    Bowyer, Georgina
    Edwards, Nick J.
    Griffiths, Oliver
    Powlson, Jonathan
    Silman, Daniel
    Morter, Richard
    Folegatti, Pedro M.
    Minassian, Angela
    Poulton, Ian
    Collins, Katharine
    Brod, Florian
    Angell-Manning, Philip
    Berrie, Eleanor
    Brendish, Nathan
    Glenn, Greg
    Fries, Louis
    Baum, Jake
    Blagborough, Andrew M.
    Roberts, Rachel
    Lawrie, Alison M.
    Lewis, David J.
    Faust, Saul N.
    Gilbert, Sarah
    Ewer, Katie J.
    Hill, Adrian V.
    AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2017, 97 (05): : 594 - 594
  • [23] Evaluation of a novel malaria anti-sporozoite vaccine candidate, R21 in Matrix-M adjuvant, in the UK and Burkina Faso: two phase 1, first-in-human trials
    Venkatraman, Navin
    Tiono, Alfred B.
    Bowyer, Georgina
    Bellamy, Duncan G.
    Stockdale, Lisa K.
    Powlson, Jonathan
    Collins, Katharine A.
    Coulibaly, Sam
    Datoo, Mehreen S.
    Silman, Daniel
    Ouedraogo, Alphonse
    Nebie, Issa
    Imoukhuede, Egeruan B.
    Brod, Florian
    Folegatti, Pedro
    Dickinson-Craig, Emma
    Jamieson, Sophie
    Bougouma, Edith C.
    Wright, Daniel
    Diarra, Amidou
    Bliss, Carly M.
    Morter, Richard
    Glenn, Greg
    Fries, Louis F.
    Reimer, Jenny M.
    Loevgren-Bengtsson, Karin
    Baker, Megan
    Poulton, Ian
    Moyle, Sarah
    Berrie, Eleanor
    Green, Nicola
    Mukhopadhyay, Ekta
    Viebig, Nicola K.
    Angus, Brian
    Lawrie, Alison
    Roberts, Rachel
    Gilbert, Sarah C.
    Lewis, David J. M.
    Sirima, Sodiomon B.
    Ewer, Katie J.
    Hill, Adrian V. S.
    LANCET MICROBE, 2025, 6 (03):
  • [24] Unlocking the potential of novel RTS, S/AS01, and R21/Matrix-M™ malaria vaccines in African nations
    Oduoye, Malik Olatunde
    Haider, Muhammad Usman
    Marsool, Mohammed Dheyaa Marsool
    Kareem, Mayowa Odunayo
    Adedayo, Adenike Ebunoluwa
    Abdulkarim, Abdulkarim Surajo
    Adegoke, Abdullahi Adeyemi
    Kaushik, Ikshwaki
    Irfan, Hamza
    Yusuf, Hassan Abdullahi
    Shah, Hussain Haider
    Karim, Karim Arif
    HEALTH SCIENCE REPORTS, 2024, 7 (01)
  • [25] A new era in malaria prevention: a comparative look at RTS,S/AS01 and R21/Matrix-M vaccines
    Al-Obeidee, Mustafa
    Al-Obeidee, Esraa
    POSTGRADUATE MEDICAL JOURNAL, 2024, 100 (1190) : 877 - 878
  • [26] LOWER VACCINE DOSE ASSOCIATES WITH ANTI-CSP ANTIBODY DURABILITY AND FUNCTION: PHASE I TRIALS OF R21/MATRIX-M IN EUROPE AND AFRICA
    Bowyer, Georgina
    Venkatraman, Navin
    Tiono, Alfred B.
    Bellamy, Duncan
    Silman, Daniel
    Flaxman, Amy
    Datoo, Mehreen
    Khan, Shahid M.
    Reimer, Jenny M.
    Sirima, Sodiomon B.
    Hill, Adrian V.
    Ewer, Katie J.
    AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2019, 101 : 528 - 528
  • [27] VACCINE HESITANCY AMONG PARENTS OF TEENS
    Roberts, J. R.
    Hale, J.
    Thompson, D.
    Darden, P.
    JOURNAL OF INVESTIGATIVE MEDICINE, 2013, 61 (02) : 453 - 453
  • [28] IMPACT OF A DELAYED AND FRACTIONATED THIRD DOSE OF R21/MATRIX-M ADJUVANT IN UK ADULTS
    Bellamy, Duncan G.
    Stockdale, Lisa
    Datoo, Mehreen
    Aboagye, Jeremy
    Sanders, Helen
    Makinson, Rebecca
    Venkatramann, Navin
    Madhaven, Meera
    Flaxman, Amy
    Edwards, Nick
    Poulton, Ian
    Baker, Megan
    Ramos-Lopez, Fernando
    Reimer, Jenny
    Shaligram, Umesh
    Hill, Adrian V.
    Ewer, Katie J.
    AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2021, 105 (05): : 372 - 372
  • [29] Novel adjuvants that promote the efficacy of R21 malaria vaccine candidate in a mouse model
    Reinke, Soren
    Ferguson, Joannah
    Dubois, Patrice
    Milicic, Anita
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2021, 51 : 114 - 114
  • [30] SAFETY AND IMMUNOGENICITY OF THE MALARIA VACCINE CANDIDATE R21 ADJUVANTED WITH MATRIX-M1 IN WEST AFRICAN ADULT VOLUNTEERS, BURKINA FASO
    Tiono, Alfred B.
    Ouedraogo, Alphonse
    Coulibaly, Sam Aboubacar
    Bougouma, Edith C.
    Ouedraogo, Issa N.
    Navin, Venkatraman
    Bowyer, Georgina
    Ewer, Katie
    Viebig, Nicola
    Diarra, Amidou
    Glenn, Gregory
    Leroy, Odile
    Hill, Adrian V.
    Sirima, Sodiomon Bienvenu
    AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2017, 97 (05): : 129 - 129